NCT01822639 - A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 3, 2013

Primary Completion Date

May 24, 2013

Study Completion Date

May 24, 2013

Conditions

Hypertension

Interventions

DRUG

GSK2944404 FDC

Uncoated, round, yellow white bilayer fixed dose combination tablet containing 5 mg amlodipine and 20 mg enalapril for single dose oral administration in each period.

DRUG

Amlodipine 5 mg

Emerald-shaped white 5 mg amlodipine table for single dose oral co-administration with enalapril maleate tablet in each period.

DRUG

Enalapril Maleate 20 mg

Peach triangle shaped 20 mg enalapril maleate tablet for single dose oral co-administration with amlodipine in each period.

Trial Locations (1)

2031

GSK Investigational Site, Randwick